SELLAS Life Sciences Group, Inc. (SLS)
3.77
+0.46
(+13.90%)
USD |
NASDAQ |
Dec 31, 16:00
3.85
+0.08
(+2.12%)
After-Hours: 20:00
SELLAS Life Sciences Group Free Cash Flow: -30.62M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GT Biopharma, Inc. | -11.36M |
| Geron Corp. | -132.68M |
| ADMA Biologics, Inc. | 40.61M |
| Lyell Immunopharma, Inc. | -165.54M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.068M |
| Cash from Financing (Quarterly) | 26.09M |
| Free Cash Flow Per Share (Quarterly) | -0.0652 |
| Free Cash Flow to Equity (Quarterly) | -6.93M |
| Free Cash Flow to Firm (Quarterly) | -7.068M |
| Free Cash Flow Yield | -8.81% |